These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37291632)

  • 1. Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France.
    Maler V; Goetz V; Tardieu M; Khalil AE; Alili JM; Meunier P; Maillot F; Labarthe F
    Orphanet J Rare Dis; 2023 Jun; 18(1):142. PubMed ID: 37291632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-protein meal plus aspartame ingestion on plasma phenylalanine concentrations in obligate heterozygotes for phenylketonuria.
    Curtius HC; Endres W; Blau N
    Metabolism; 1994 Apr; 43(4):413-6. PubMed ID: 8159095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accidental Consumption of Aspartame in Phenylketonuria: Patient Experiences.
    Newbould E; Pinto A; Evans S; Ford S; O'Driscoll M; Ashmore C; Daly A; MacDonald A
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33672234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartame: review of recent experimental and observational data.
    Janssen PJ; van der Heijden CA
    Toxicology; 1988 Jun; 50(1):1-26. PubMed ID: 3291200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Protein Intake in Children with Phenylketonuria: Prescription vs. Actual Intakes.
    Pinto A; Daly A; Rocha JC; Ashmore C; Evans S; Ilgaz F; Hickson M; MacDonald A
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartame and Phe-Containing Degradation Products in Soft Drinks across Europe.
    van Vliet K; Melis ES; de Blaauw P; van Dam E; Maatman RGHJ; Abeln D; van Spronsen FJ; Heiner-Fokkema MR
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32599819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition after a 4-week high phenylalanine intake in adults with phenylketonuria - a randomized controlled trial.
    Trepp R; Muri R; Maissen-Abgottspon S; Haynes AG; Hochuli M; Everts R
    Am J Clin Nutr; 2024 Apr; 119(4):908-916. PubMed ID: 38569786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an aspartame loading test for the detection of heterozygotes for classical phenylketonuria.
    Silva LC; Pires RF; Coelho JC; Jardim LB; Giugliani R
    Clin Genet; 1997 Apr; 51(4):231-5. PubMed ID: 9184243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
    Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
    PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of phenylalanine molecularly imprinted polymer (MIP) benefits PKU mouse model.
    Torab M; Jafari-Sabet M; Najafizadeh P; Sadegipour A; Rahimi-Moghaddam P; Ebrahimi SA
    J Inherit Metab Dis; 2022 Jul; 45(4):696-709. PubMed ID: 35527480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS; Yannicelli S; White BD; Medeiros DM
    Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut-Microbiome Composition in Response to Phenylketonuria Depends on Dietary Phenylalanine in BTBR Pah
    van der Goot E; Vink SN; van Vliet D; van Spronsen FJ; Falcao Salles J; van der Zee EA
    Front Nutr; 2021; 8():735366. PubMed ID: 35059423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
    Ney DM; Hull AK; van Calcar SC; Liu X; Etzel MR
    J Nutr; 2008 Feb; 138(2):316-22. PubMed ID: 18203898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.
    Whitehall KB; Rose S; Clague GE; Ahring KK; Bilder DA; Harding CO; Hermida Á; Inwood A; Longo N; Maillot F; Muntau AC; Pessoa ALS; Rocha JC; Rohr F; Sivri S; Said J; Oshinbolu S; Sibbring GC
    Orphanet J Rare Dis; 2024 Aug; 19(1):293. PubMed ID: 39135125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria.
    Zori R; Ahring K; Burton B; Pastores GM; Rutsch F; Jha A; Jurecki E; Rowell R; Harding C
    Mol Genet Metab; 2019; 128(1-2):92-101. PubMed ID: 31439512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nutrition in pregnancy with phenylketonuria and birth defects.
    Matalon KM; Acosta PB; Azen C
    Pediatrics; 2003 Dec; 112(6 Pt 2):1534-6. PubMed ID: 14654660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient phenylketonuria in premature infants.
    Salamanca-Zarzuela B; López MEI; Martín CA
    Nutrition; 2019 Mar; 59():180-181. PubMed ID: 30504004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of the Low Phenylalanine Diet for Patients with Phenylketonuria and the Benefits of Increased Natural Protein.
    McWhorter N; Ndugga-Kabuye MK; Puurunen M; Ernst SL
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.